Andrew Holland, CEO of Avendus Capital Public Markets Alternate Strategies LLP, discusses the impact of FII selling on bank stocks and the upcoming market trends post-elections. Coming to pharma, Holland says the bottom was hit some months back for the whole sector and the prospects are starting to look better not just locally but overseas as well.
CMR Green Technologies IPO Day 3: Issue booked over 127 times on strong QIB demand; 40% GMP signals strong listing premium
CMR Green Technologies’ IPO saw a strong subscription of 127 times, with QIBs leading the demand. The issue, an offer-for-sale, garnered a grey market premium